Compass Therapeutics, Inc. (CMPX) vs Oramed Pharmaceuticals Inc. (ORMP)
A side-by-side comparison of Compass Therapeutics, Inc. and Oramed Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CMPX
Compass Therapeutics, Inc.
$0.97HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
ORMP
Oramed Pharmaceuticals Inc.
$4.44HealthcareDelayed quote: Oct 6, 2026, 1:49 PM EDT
Total return — CMPX vs ORMP
growth of $100 · dividends reinvested · last 6yCMPX -88.7% (-30.5%/yr)ORMP -52.4% (-11.6%/yr)ORMP compounded faster over this window
CMPX ORMP
CMPX vs ORMP: by the numbers
- •ORMP is the larger company ($182M vs $175M market cap).
- •ORMP is profitable (3202.50% net margin) while CMPX runs a net loss (0.00%).
- •ORMP pays a dividend (5.59% yield), while CMPX has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | CMPX | ORMP |
|---|---|---|
| P/E ratio | N/A | 1.08 |
| P/B ratio | 1.06 | 0.57 |
Profitability
| Metric | CMPX | ORMP |
|---|---|---|
| Gross margin | 0.00% | 0.65% |
| Operating margin | 0.00% | -754.40% |
| Net margin | 0.00% | 3202.50% |
| ROE | -44.23% | 55.08% |
| ROIC | -46.59% | -3.21% |
Dividends
| Metric | CMPX | ORMP |
|---|---|---|
| Dividend yield | N/A | 5.59% |
| Payout ratio | N/A | 6.08% |
Growth (annualized)
| Metric | CMPX | ORMP |
|---|---|---|
| Total return CAGR (5Y) | -22.79% | -25.80% |
Frequently asked
- Does CMPX or ORMP pay a bigger dividend?
- ORMP pays a dividend (5.59% yield), while CMPX has no payments in the available dividend history.
- Is CMPX or ORMP more profitable?
- ORMP runs the higher net margin — CMPX at 0.00% versus ORMP at 3202.50%.
- How have CMPX and ORMP total returns compared?
- Over the past 5 years, CMPX delivered -22.79% and ORMP delivered -25.80% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Oramed Pharmaceuticals P/E ratioOramed Pharmaceuticals dividend yieldCompass Therapeutics ROEOramed Pharmaceuticals ROECompass Therapeutics operating marginOramed Pharmaceuticals operating marginCompass Therapeutics revenue growthOramed Pharmaceuticals revenue growthCompass Therapeutics free cash flowOramed Pharmaceuticals free cash flow
Compass Therapeutics & Oramed Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.